Vivoryon Therapeutics N.V. (VVY)
Market Closed
15 Oct, 03:30 PM
€
0. 99
-0.05
-4.8077%
€
57.87M Market Cap
- P/E Ratio
- Div Yield
65,917 Volume
- Eps
€ 1.04
Previous Close Want to track VVY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vivoryon Therapeutics N.V. (VVY) Statistics
Valuation metrics
Market Cap 57.87M
Enterprise value 28.73M
Trailing P/E (ttm) -4.57
Forward P/E -
PEG ratio -0.06
Price/Sales (ttm) -
Price/Book (mrq) 19.87
Enterprise Value/Revenue -
Enterprise Value/EBITDA -4.16
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 29.21K
Average volume (90 days) 28.16K
Price summary
52-Week low 0.98
52-Week high 1.68
Beta -
50-Day moving average 1.11
200-Day moving average 1.19
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 256:251
Last split Date 10 Oct 2019
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.62%
Return on equity -2.15%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.23
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.08
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 4.56%
Book value per share (mrq) 0.05
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
